Beximco Pharma (BXP.L): Wins Company of the Year Award | Novacyt plc (NCYT.L): New term loan and termination of convertible bond facility | Hemogenyx Pharma (HEMO.L): Attendance at US oncology conference
07 Nov 2019
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions
Beximco Pharmaceuticals Limited Sponsored GDR RegS (BXP:LON), 37.0 | Novacyt SAS (NCYT:LON), 64.8 | HemoGenyx Pharmaceuticals Plc (HEMO:LON), 1.6
- Published:
07 Nov 2019 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
4
Beximco Pharma (BXP.L): Wins Company of the Year Award | Novacyt plc (NCYT.L): New term loan and termination of convertible bond facility | Hemogenyx Pharma (HEMO.L): Attendance at US oncology conference